Mark Schroeder, M.D.
Washington University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mark Schroeder, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:15 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05820763 · Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplantWashington University School of Medicine · withdrawn · Multiple Myeloma, Myeloma-Associated Amyloidosis · principal investigator
- Ph1NCT04006652 · ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant RecipientsWashington University School of Medicine · terminated · Acute Graft Versus Host Disease, Haploidentical Hematopoietic Stem Cell Transplant · principal investigator
- Ph1NCT02750254 · Azacitidine in Haploidentical Donor Hematopoietic Cell TransplantationWashington University School of Medicine · terminated · Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia · principal investigator
- Ph1NCT01700751 · Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell TransplantationWashington University School of Medicine · completed · Leukemia, Acute Myeloid, Leukemia, Lymphoblastic,Acute, Myelodysplastic Syndromes · principal investigator
- Ph2NCT01158118 · Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling DonorsWashington University School of Medicine · completed · Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Lymphoma, Non-Hodgkin · principal investigator
- Ph1NCT01065129 · Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)Washington University School of Medicine · completed · Myelodysplastic Syndromes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in multiple myeloma.